Skip to main content

Published locations for Daclizumab Reduces MS Relapse Rate by 45%, Compared With Interferon β-1a

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Daclizumab Reduces MS Relapse Rate by 45%, Compared With Interferon β-1a

User login

  • Reset your password
  • /content/daclizumab-reduces-ms-relapse-rate-45-compared-interferon-v-1a
  • /neurologyreviews/article/99883/multiple-sclerosis/daclizumab-reduces-ms-relapse-rate-45-compared
  • /multiplesclerosishub/article/99883/multiple-sclerosis/daclizumab-reduces-ms-relapse-rate-45-compared
  • /neurology/article/99883/multiple-sclerosis/daclizumab-reduces-ms-relapse-rate-45-compared-interferon
  • /neurology/msresourcecenter/article/99883/multiple-sclerosis/daclizumab-reduces-ms-relapse-rate-45